Related Experiment Video
Updated: Jul 16, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Interpretable Machine Learning Models for Early Detection of Metabolic Dysfunction-Associated Steatotic Liver Disease
Yuan-Hao You1,2, Li-Yun Chen1,3, Alexander Valley Chang1,4
1In-Service Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Machine learning models accurately detect metabolic dysfunction-associated steatotic liver disease (MASLD) using routine clinical data. This approach aids in early risk stratification and prioritizing patients for further evaluation.
Area of Science:
- Medical Informatics
- Machine Learning in Healthcare
- Liver Disease Diagnostics
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern.
- Early detection and risk stratification are crucial for managing MASLD.
- Non-invasive methods are needed to supplement traditional diagnostic tools.
Purpose of the Study:
- To develop and evaluate interpretable machine learning models for early MASLD detection.
- To utilize routine clinical and laboratory data for MASLD risk stratification.
- To assess the feasibility of using MRI-PDFF-calibrated models in clinical settings.
Main Methods:
- Retrospective analysis of 152 patients' clinical and laboratory data.
- Development and comparison of ten interpretable machine learning models.
- Validation using magnetic resonance imaging proton density fat fraction (MRI-PDFF) and Shapley Additive Explanations (SHAP).
Main Results:
- Logistic Regression showed high discriminative performance (AUC = 0.873).
- Random Forest achieved the best overall classification (accuracy = 0.816, F1-score = 0.807).
- Key predictors identified: Hepatic Steatosis Index (HSI), body fat, age, and triglycerides (TG).
Conclusions:
- Interpretable machine learning models using routine data are feasible for MASLD risk stratification.
- SHAP analysis identified significant metabolic and anthropometric risk factors.
- This approach can help prioritize patients for imaging and further evaluation.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
